Binimetinib is an MEK inhibitor. It’s used with encorafenib to treat melanoma with the BRAF V600E/K mutation. It blocks MEK signaling to work.
You can get it in 15 mg film-coated tablets. The suggested dose is 45 mg, taken twice a day. Binimetinib tablets are sold in bottles with 84 pills.
It’s for a kind of melanoma with a BRAF mutation. It’s used with another med called encorafenib. It’s meant to be taken by mouth and is part of a combo treatment plan.
Reviews
There are no reviews yet.